Innospec Stock Analysis

IOSP Stock  USD 78.14  0.42  0.53%   
Innospec is undervalued with Real Value of 87.94 and Target Price of 99.33. The main objective of Innospec stock analysis is to determine its intrinsic value, which is an estimate of what Innospec is worth, separate from its market price. There are two main types of Innospec's stock analysis: fundamental analysis and technical analysis.
The Innospec stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Innospec is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Innospec Stock trading window is adjusted to America/New York timezone.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Innospec Stock, please use our How to Invest in Innospec guide.

Innospec Stock Analysis Notes

About 100.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.5. Some equities with similar Price to Book (P/B) outperform the market in the long run. Innospec recorded a loss per share of 0.04. The entity last dividend was issued on the 18th of November 2025. The firm had 2:1 split on the 23rd of July 2007. Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado. Innospec operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. It employs 1900 people. To learn more about Innospec call Patrick Williams at 303 792 5554 or check out https://innospec.com.

Innospec Quarterly Total Revenue

441.9 Million

Innospec Investment Alerts

Over 100.0% of the company shares are owned by institutional investors
On 26th of November 2025 Innospec paid $ 0.87 per share dividend to its current shareholders
Latest headline from news.google.com: Can Innospec Inc. stock sustain revenue growth - July 2025 Pullbacks Safe Entry Trade Reports - DonanmHaber

Innospec Upcoming and Recent Events

13th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Innospec Largest EPS Surprises

Earnings surprises can significantly impact Innospec's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2002-02-12
2001-12-310.140.160.0214 
2001-10-29
2001-09-300.120.140.0216 
2001-04-30
2001-03-310.080.06-0.0225 
View All Earnings Estimates

Innospec Environmental, Social, and Governance (ESG) Scores

Innospec's ESG score is a quantitative measure that evaluates Innospec's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Innospec's operations that may have significant financial implications and affect Innospec's stock price as well as guide investors towards more socially responsible investments.

Innospec Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Charles Schwab Investment Management Inc2025-06-30
356.2 K
Millennium Management Llc2025-06-30
350 K
Jpmorgan Chase & Co2025-06-30
321.2 K
Qube Research & Technologies2025-06-30
306.8 K
Northern Trust Corp2025-06-30
302.5 K
Nuveen, Llc2025-06-30
296 K
Bank Of America Corp2025-06-30
295.5 K
Morgan Stanley - Brokerage Accounts2025-06-30
263.8 K
Hhg Plc2025-06-30
255.4 K
Blackrock Inc2025-06-30
3.7 M
Vanguard Group Inc2025-06-30
3.2 M
Note, although Innospec's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Innospec Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.95 B.

Innospec Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets 0.03  0.03 
Return On Capital Employed 0.13  0.10 
Return On Assets 0.02  0.02 
Return On Equity 0.03  0.03 

Management Efficiency

As of 12/31/2025, Return On Tangible Assets is likely to drop to 0.03. In addition to that, Return On Capital Employed is likely to drop to 0.1. At this time, Innospec's Non Current Liabilities Total is relatively stable compared to the past year. As of 12/31/2025, Change To Liabilities is likely to grow to about 78.1 M, while Total Current Liabilities is likely to drop slightly above 240.4 M. Innospec's management efficiency ratios could be used to measure how well Innospec manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 48.78  51.22 
Tangible Book Value Per Share 30.81  32.35 
Enterprise Value Over EBITDA 27.93  29.33 
Price Book Value Ratio 2.27  1.33 
Enterprise Value Multiple 27.93  29.33 
Price Fair Value 2.27  1.33 
Enterprise Value1.7 B1.7 B
Leadership at Innospec emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Dividend Yield
0.0208
Operating Margin
0.0701
Profit Margin
(0.0007)
Forward Dividend Yield
0.0222
Beta
0.918

Technical Drivers

As of the 31st of December, Innospec retains the Risk Adjusted Performance of 0.0282, downside deviation of 1.36, and Market Risk Adjusted Performance of 0.051. Innospec technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Innospec Price Movement Analysis

The output start index for this execution was one with a total number of output elements of sixty. The Parabolic SAR indicator is used to determine the direction of Innospec's momentum and the point in time when Innospec has higher than normal probability directional change.

Innospec Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Innospec insiders, such as employees or executives, is commonly permitted as long as it does not rely on Innospec's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Innospec insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Innospec Outstanding Bonds

Innospec issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Innospec uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Innospec bonds can be classified according to their maturity, which is the date when Innospec has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Innospec Predictive Daily Indicators

Innospec intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Innospec stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Innospec Corporate Filings

F4
17th of November 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
5th of November 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
6th of August 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
30th of May 2025
Other Reports
ViewVerify
F4
15th of May 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
14th of May 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
13th of May 2025
An amended filing to the original Schedule 13G
ViewVerify
8K
9th of May 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Innospec Forecast Models

Innospec's time-series forecasting models are one of many Innospec's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Innospec's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Innospec Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Innospec prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Innospec shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Innospec. By using and applying Innospec Stock analysis, traders can create a robust methodology for identifying Innospec entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.02  0.02 
Operating Profit Margin 0.10  0.11 
Net Profit Margin 0.02  0.02 
Gross Profit Margin 0.29  0.39 

Current Innospec Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Innospec analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Innospec analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
99.33Strong Buy2Odds
Innospec current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Innospec analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Innospec stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Innospec, talking to its executives and customers, or listening to Innospec conference calls.
Innospec Analyst Advice Details

Innospec Stock Analysis Indicators

Innospec stock analysis indicators help investors evaluate how Innospec stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Innospec shares will generate the highest return on investment. By understating and applying Innospec stock analysis, traders can identify Innospec position entry and exit signals to maximize returns.
Begin Period Cash Flow203.7 M
Common Stock Shares Outstanding25.1 M
Total Stockholder Equity1.2 B
Total Cashflows From Investing Activities-62 M
Tax Provision5.6 M
Quarterly Earnings Growth Y O Y-0.609
Property Plant And Equipment Net314.5 M
Cash And Short Term Investments289.2 M
Cash289.2 M
Accounts Payable163.8 M
Net Debt-244.3 M
50 Day M A75.1088
Total Current Liabilities371.4 M
Other Operating Expenses1.7 B
Non Current Assets Total778.1 M
Forward Price Earnings14.1044
Non Currrent Assets Other6.3 M
Stock Based Compensation8.5 M

Additional Tools for Innospec Stock Analysis

When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.